Key Financial Data Of Reporting Company

Astellas Pharma Inc. - Filing #7577637

Concept As at
2022-12-31
As at
2022-03-31
As at
2021-12-31
Key financial data of reporting company
Business results of reporting company
Cash and cash equivalents
381,816,000,000 JPY
315,986,000,000 JPY
350,213,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.